Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1056_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
23 Мб
Скачать
468 G. Naldini et al.
García-Aguilar J, Davey CS, Le CT, Lowry AC, Rothenberger DA (2000) Patient satisfaction after
surgical treatment for stula-in-ano. Dis Colon Rectum 43(9):1206–12. https://doi.org/10.1007/
BF02237422. PMID: 11005484
Garcia-Arranz M, Garcia-Olmo D, Herreros MD, Gracia-Solana J, Guadalajara H, de la Portilla F,
... Prosper F (2020) Autologous adipose-derived stem cells for the treatment of complex
cryptoglandular perianal stula: A randomized clinical trial with long-term follow-up. Stem
Cells Transl Med 9(3):295–301. https://doi.org/10.1002/sctm.19-0271 García-Olmo D, García-Arranz M, Gómez García L, Cuellar ES, Blanco IF, Prianes LA, ... García-
Sancho L (2003) Autologous stem cell transplantation for treatment of rectovaginal stula in
perinatal Crohns disease: a new cell-based therapy. Int J Color Dis 18(5):451–454. https://doi.
org/10.1007/s00384-003-0490-3
Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, ... Pascual M (2009)
Expanded adipose-derived stem cells for the treatment of complex perianal stula: a phase II
clinical trial. Dis Colon Rectum 52(1):79–86. https://doi.org/10.1007/DCR.0b013e3181973487 García-Olmo D, Van Assche G, Tagarro I, Diez MC, Richard MP, Khalid JM, ... Panés J (2019)
Prevalence of anal stulas in Europe: systematic literature reviews and population-based
database analysis. Adv Ther 36(12):3503–3518. https://doi.org/10.1007/s12325-019-01117-y Georgiev-Hristov T, Guadalajara H, Herreros MD, Lightner AL, Dozois EJ, García-Arranz M,
García-Olmo D (2018) A Step-By-Step Surgical Protocol for the Treatment of Perianal Fistula
with Adipose-Derived Mesenchymal Stem Cells. J Gastrointest Surg 22(11):2003-2012. https://
doi.org/10.1007/s11605-018-3895-6. Epub 2018 Jul 31. PMID: 30066070
Goujon E (1869) J de LAnat et de La Physiol (6):399–412 Guadalajara H, Herreros D, De-La-Quintana P, Trebol J, Garcia-Arranz M, Garcia-Olmo D (2012)
Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to
treat complex perianal stulas. Int J Color Dis 27(5):595–600. https://doi.org/10.1007/s00384-
011-1350-1
Hass R, Kasper C, Böhm S, Jacobs R (2011) Different populations and sources of human
mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell
Commun Signal 9. https://doi.org/10.1186/1478-811X-9-12 Herreros MD, Garcia-Arranz M, Guadalajara H, De-La-Quintana P, Garcia-Olmo D (2012) Autol-
ogous expanded adipose-derived stem cells for the treatment of complex cryptoglandular
perianal stulas: a phase III randomized clinical trial (FATT 1: stula advanced therapy trial
1) and long-term evaluation. Dis Colon Rectum 55(7):762–772. https://doi.org/10.1097/DCR.
0b013e318255364a
Herreros MD, Garcia-Olmo D, Guadalajara H, Georgiev-Hristov T, Brandariz L, Garcia-Arranz M
(2019) Stem cell therapy: A compassionate use program in perianal stula. Stem Cells Int.
https://doi.org/10.1155/2019/6132340. PMID: 31191678; PMCID: PMC6525789
Illouz YG (1983) Body contouring by lipolysis: a 5-year experience with over 3000 cases. Plast
Reconstr Surg 72(5):591–597. https://doi.org/10.1097/00006534-198311000-00001 Kontovounisios C, Tekkis P, Tan E, Rasheed S, Darzi A, Wexner SD (2016) Adoption and success
rates of perineal procedures for stula-in-ano: a systematic review. Color Dis 18(5):441
https://doi.org/10.1111/codi.13330
Kotze PG, Spinelli A, Warusavitarne J, Di Candido F, Sahnan K, Adegbola SO, Danese S (2019)
Darvadstrocel for the treatment of patients with perianal stulas in Crohns disease. Drugs
Today 55(2):95–105. https://doi.org/10.1358/dot.2019.55.2.2914336 Laureti S, Gionchetti P, Cappelli A, Vittori L, Contedini F, Rizzello F, ... Poggioli G (2020)
Refractory complex Crohns perianal stulas: a role for autologous microfragmented adipose
tissue injection. Inamm Bowel Dis 26(2):321–330. https://doi.org/10.1093/ibd/izz051 Lazarus HM, Haynesworth SE, Gerson SL, Caplan AI (1997) Human bone marrow-derived
mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood
progenitor cell collections. J Hematother Stem Cell Res 6(5):447–455. https://doi.org/10.1089/
scd.1.1997.6.447
–458.
28 Stem Cells in Cryptoglandular Anal Fistulas 469
Lunniss PJ, Kamm MA, Phillips RKS (1994) Factors affecting continence after surgery for anal
stula. Br J Surg 81(9):1382–1385. https://doi.org/10.1002/bjs.1800810947 Majumdar M, Thiede M, Mosca J, Moorman M, Gerson SL (1998) Phenotypic and functional
comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells.
J Cell Physiol 176(1). https://doi.org/10.1002/(SICI)1097-4652(199807)176:1<57::AID-
JCP7>3.0.CO;2-7
Mestak O, Sukop A, Hsueh YS, Molitor M, Mestak J, Matejovska J, Zarubova L (2014) Centrifu-
gation versus PureGraft for fatgrafting to the breast after breast-conserving therapy. World
J Surg Oncol 12(1). https://doi.org/10.1186/1477-7819-12-178 Naldini G, Sturiale A, Fabiani B, Giani I, Menconi C (2018) Micro-fragmented adipose tissue
injection for the treatment of complex anal stula: a pilot study accessing safety and feasibility.
Tech Coloproctol. https://doi.org/10.1007/s10151-018-1755-8 Narang SK, Keogh K, Alam NN, Pathak S, Daniels IR, Smart NJ (2017) A systematic review of
new treatments for cryptoglandular stula in ano. Surgeon 15(1):30–39. https://doi.org/10.1016/
j.surge.2016.02.002
Nava S, Sordi V, Pascucci L, Tremolada C, Ciusani E, Zeira O, ... Alessandri G (2019) Long-
lasting anti-inammatory activity of human microfragmented adipose tissue. Stem Cells Int, 1–
13. https://doi.org/10.1155/2019/5901479
Parks AG, Gordon PH, Hardcastle JD (1976) A classication of stula-in-ano. Br J Surg 63(1):1–
12. https://doi.org/10.1002/bjs.1800630102
Regulation(EC) No. 1394/2007 of the European Parliament and of the Council (n.d.). Retrievedfrom
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri¼OJ:L:2007:324:0121:0137:en:PDF
Ren H, Sang Y, Zhang F, Liu Z, Qi N, Chen Y (2016) Comparative analysis of human mesenchymal
stem cells from umbilical cord, dental pulp, and menstrual blood as sources for cell therapy.
Stem Cells Int. https://doi.org/10.1155/2016/3516574 Sainio P (1984) Fistula-in-ano in a dened population. Incidence and epidemiological aspects. Ann
Chir Gynaecol 73(4):219–224 Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB (2003) American gastroenterological associa-
tion technical review on perianal Crohns disease. Gastroenterology 125(5):1508–1530. https://
doi.org/10.1053/S0016-5085(03)01367-2
Stolzing A, Jones E, McGonagle D, Scutt A (2008) Age-related changes in human bone marrow-
derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 129(3):
163–173. https://doi.org/10.1016/j.mad.2007.12.002 Strem BM, Hicok KC, Zhu M, Wulur I, Alfonso Z, Schreiber RE, ... Hedrick MH (2005)
Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 54:132–141.
https://doi.org/10.2302/kjm.54.132
Taha AA, Tahseen H (2020) Spreading awareness. Plast Reconstr Surg – Glob Open 8(3):e2715.
https://doi.org/10.1097/gox.0000000000002715
Tavassoli M, Crosby WH (1968) Transplantation marrow. Science 161(3836):54–56 Vangsness CT, Sternberg H, Harris L (2015) Umbilical cord tissue offers the greatest number of
harvestable mesenchymal stem cells for research and clinical application: a literature review of
different harvest sites. Arthroscopy – J Arthrosc Related Surg 31:1836–1843. https://doi.org/10.
1016/j.arthro.2015.03.014
Von Heimburg D, Hemmrich K, Haydarlioglu S, Staiger H, Pallua N (2004) Comparison of viable
cell yield from excised versus aspirated adipose tissue. Cells Tissues Organs 178(2):87
https://doi.org/10.1159/000081719
Zakine G, Baruch J, Dardour JC, Flageul G (2015) Perforation of viscera, a dramatic complication
of liposuction: a review of 19 cases evaluated by experts in France between 2000 and 2012. Plast
Reconstr Surg 135(3):743–750. https://doi.org/10.1097/PRS.0000000000001030 Zanotti C, Martinez-Puente C, Pascual I, Pascual M, Herreros D, García-Olmo D (2007) An
assessment of the incidence of stula-in-ano in four countries of the European Union. Int
J Color Dis 22(12):1459–1462. https://doi.org/10.1007/s00384-007-0334-7
–92.
470 G. Naldini et al.
Zhao RC (2013) Essentials of mesenchymal stem cell biology and its clinical translation. In:
Essentials of mesenchymal stem cell biology and its clinical translation, pp 1–313. https://doi.
org/10.1007/978-94-007-6716-4
Zhou C, Li M, Zhang Y, Ni M, Wang Y, Xu D, Shi Y, Zhang B, Chen Y, Huang Y, Zhang S, Shi H,
Jiang B (2020) Autologous adipose-derived stem cells for the treatment of Crohns stula-in-
ano: an open-label, controlled trial. Stem Cell Res Ther 11(1):124. https://doi.org/10.1186/
s13287-020-01636-4. PMID: 32183875; PMCID: PMC7079384
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, ... Hedrick MH (2001) Multilineage
cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7(2):211–
228. https://doi.org/10.1089/107632701300062859
Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, ... Hedrick MH (2002) Human
adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13(12):4279–4295. https://
doi.org/10.1091/mbc.E02-02-0105
Additional Surgical Options to Treat Anal Fistulas: Gracilis Interposition, Martius Flap,
29
and Gluteal Flap
Douglas Morte, Jace Franko, and Scott R. Steele
Contents
1 Introduction . ............... .................................................................. 472
2 Perianal and Rectovaginal Fistulas ......................................................... 473
2.1 Epidemiology and Diagnosis ......................................................... 473
2.2 Classication .................. .................................. ...................... 475
2.3 Treatment Modalities . . ................................................................ 476
3 Flap Reconstruction .... ....................................... .............................. 478
3.1 Overview and Considerations for Flap Reconstruction .............................. 478
4 Gracilis Interposition Flap ................................................................... 481
4.1 Background and Indications .......................................................... 481
4.2 Operative Technique .................................................................. 481
4.3 Results/Complications ................................................................. 483
5 Martius Interposition Flap . .................................................................. 484
5.1 History and Indications ............................................................... 484
5.2 Surgical Technique ..... . . . . ...... . . . . ...... . . . ....... . . . ...... . . . . ...... . . . . ...... . . . . 484
5.3 Results/Complications ................................................................. 487
6 Gluteal Muscle Interposition Flap .......................................................... 488
6.1 History and Indications ............................................................... 488
6.2 Surgical Technique ..... . . . . ...... . . . . ...... . . . ....... . . . ...... . . . . ...... . . . . ...... . . . . 488
6.3 Results/Complications ................................................................. 489
7 Conclusion ................................................................................... 490
References ............................ ............................................... ............ 491
Abstract
Anal stulas are a common, but often difcult, disease process for the colorectal and general surgeon to treat. Fistulas generally develop following cryptoglandular infection of the anal canal that results in anorectal abscesses and ultimately in approximately 30–40%, anal stulas. Additionally, patients with
D. Morte · J. Franko Department of Surgery, Madigan Army Medical Center, Fort Lewis, WA, USA
S. R. Steele ( Department of Colorectal Surgery, Cleveland Clinic, Cleveland, OH, USA
© Springer Nature Switzerland AG 2022 C. Ratto et al. (eds.), Anal Fistula and Abscess, Coloproctology,
https://doi.org/10.1007/978-3-030-76670-2_31
*)
471
472 D. Morte et al.
Crohns disease and in those patients with underlying cancer, radiation, and obstetrical trauma can develop anal stulas that can be particularly challenging to manage. Classication schemes are based on the relationship of the stula to the anal sphincter complex. While low-lying intersphincteric and transsphincteric
stulas are often successfully treated with stulotomy or setons, recurrentstulas require a more varied approach, keeping in mind the delicate balance
between healing and preservation of continence. Choices include seton place­ment, brin glue , collagen plugs, stulotomy, ligation of intersphincteric tract, transabdominal approaches, advancement aps, and episioproctotomy. When these approaches fail, patients may require more complex procedures to include muscle interposition aps. Three of the most commonly used aps are the gracilis interposition ap, the Martius ap, and the gluteal fold ap. The success of these aps is generally quite high, ranging from 75 to 92% in some series, while patients with underlying m alignancy, Crohnsdisease,or prior radiation are associated with lower rates of 33–66%. In this chapter we will provide an overview of anal stulas, briey describe the options for treatment, and provide a review of the indications, technique, and results of these muscle interposition aps.

1 Introduction

Anal stu las are a common pathology encountered by healthcare providers. These stulas routinely cause signicant social and physiologic distress to patients a nd can often require multiple procedures in an attempt to heal. Most commonly, anal stulas develop following anorectal abscesses, but they can also develop in the setting of Crohn’s disease, cancer, radiation, and trauma. The latter categories of which are often grouped – along with recurrent stulas – into complex stula s and are associated with lower rates of healing. Rectovaginal stulas are a spec ic category of perianal stula, accounting for <5%, b ut are notable for a lack of a well-dened strategy for treatment – desp ite a somewhat wide range of therapeutic options (Tsang and Rothenberger 1997). In gener al, anorectal stulas have historically been treated in accordance with the degree of sphincter involvement, as well as the underlying path ology. Options include simple drainage, setons, stulotomy, ligation of intersphincteric tract (LIFT) procedure, advancement aps, muscle transpositions , and resection and pull­through procedures. The failure rates of these techniques are widely variable, ranging from 0% to 80% in select studies (Wiskind and Thompson 1992;Gajsek et al. 2011), though many of these patients may progress on to a suc cessful repair with repeat procedures (Pinto et al. 2010).
In this chapter, we will provide a brief overview of the pathophysiology and evaluation of perianal and rectovaginal stulas and discuss treatment options for these patients with a specic focus on muscle interposition grafts.
29 Additional Surgical Options to Treat Anal Fistulas: Gracilis... 473

2 Perianal and Rectovaginal Fistulas

2.1 Epidemiology and Diagnosis
Perianal stulas are an abnormal, epithelialized connection between the rectum or anus and the perineal skin that typically result from chronic inammation. A rectovaginal stula is a subty pe of these stulas that develops between the anorectum and the vagina. Both perianal and rectovaginal stulas can be emotion­ally, physically, and socially distressing to patients due to their presence, sequela, and frequent recurrence despite appropriate treatment. Despite an extensive experi­ence and options, there is no universally accepted treatment algorithm due to variability in their underlying cause, presentation, degree of symptoms, and location.
One method of stratifying these stulas is whether they are congenital or acquired. Congenital stulas are extremely rare and generally present shortly after birth, typically in the setting of anorectal atresias or malformations in the genitouri­nary system. The management of congenital stulas is generally performed by specialized pediatric surgeons and beyond the scope of this chapter (Levitt and Pena 2005; Bailez et al. 2010; Tiwari et al. 2017).
On the contrary, acquired stulas are much more common in the adult population, with anorectal abscess as the inciting problem in the vast majority of patients. By this mechanism, anorectal abscesses develop following blockage of the anal crypts of Morgagni, leading to infection and inammation which, depending on the location of the abscess, will track to either the skin or the vagina. Fistulas develop in around 30–40% of patients with anorectal abscesses and are generally thought to be a chronic form state of the disease (Bernstein and Schehebar 2020).
Crohns disease is another common cause of perianal and rectovaginal stulas (Schwartz et al. 2002). Schwartz and colleagues found that 20% of patients with Crohns disease experienced at least one anorectal stula in a 25-year period and stulas accounted for 50–87% of the perianal lesions encountered in Crohns patients. Fistulas are more frequently associated with patients manifesting colitis versus those with an isolated ileal disease, and their presence placed patients at a higher risk for recurrent stula after treatment. Additionally, rectovaginal stulas were found to have a prevalence of 10% of women with Crohns disease and perianal complaints (Schwartz et al. 2002; Radcliffe et al. 1988). Unfortunately, perianal disease in Crohns patients tends to portend a much worse prognosis, with a more potent disease, and medical therapy remains a major part of treatment. More recently, biological therapy such as iniximab has been demonstrated to have effectively in Crohns perianal disease, though some will require temporary diversion for symptom control (62%), and a small, yet not insignicant, number, will require either perma­nent diversion (16%) or even proctectomy (41%) for management of their disease (Galandiuk et al. 2005).
Malignancy can also lead to stula formation secondary to the local invasion through healthy tissues by the tumor. The most common malignancies associated
474 D. Morte et al.
with stula are vaginal, anal, and rectal cancer. Patients with concern for a possible malignancy must be carefully and thoroughly evaluated, including tissue diagnosis and full oncological staging, as a prompt diagnosis is critical appropriate initiation of treatment and hopefully cure. For those patients with post-therapy recurrence (i.e., postoperative or following chemo +/radiation therapy), it is imperative to determine if the stula represents a recurrence of the original tumor or other complication from the surgery, such as an anastomotic leak. With such distinguishing origins, the treatment options will be widely disparate.
Radiation injury to the rectum (i.e., treatment of prostate cancer) resulting in chronic radiation proctitis can also lead to the development of perianal stulas. These stulas will generally occur late, around 6–24 months after treatment, resulting from inammatory and ulcerative damage secondary to endarteritis obliterans and tissue hypoxia. Patients with higher doses of radiation and vascular risk factors to include diabetes, smoking, and hypertension are at increased risk (Gazala and Wexner 2017). Radiation is also used as a primary treatment modality for anal cancer, thus not only causing injury to the surrounding tissue that may affect management options for the stula, but also highlights the need to rule out recalci­trant or recurrent malignancy.
Trauma, specically obstetrical trauma, is also a signicant risk factor for the development of rectovaginal stulas. Obstetric trauma accounts for 80% of acquired RVF (Senatore Jr 1994). They generally develop after perineal tears that were either not recognized at the time of injury or had a disrupted repair. Vaginal wall necrosis from fetal compression or instrumentation can lead to rectovaginal stulas, as the septum above the anal sphincter complex is thin (<10 mm). This thin rectovaginal septum also places patients undergoing colorectal or coloanal anastomoses and gynecologic surgeries at increased risk for iatrogenic injury, such as the incorpora­tion of the septum into a staple line.
Concern for a perianal stula should arise in patients with a history of anorectal abscess that does not heal with time. These patients will typically present with pain, purulent or bloody discharge, and recurrent abscesses. In the case of rectovaginal stulas, patients will describe gas or stool in the vagina, freque nt urinary tract infections, perianal pain, and dyspareunia. A patient presen ting with these symptoms should prompt a thorough history with specic attention to their history of cancer, obstetrical history, concern for Crohns disease, continence status, prior anorectal surgery, prior pelvic radiation, and any history of prior stulas with subsequent treatment. It is also important to get an understanding of the impact that this stula is having on the patients life.
Once the history is complete, the next step is to perform an examination of the perianal and vaginal region with the goal of localizi ng the stula. The area will typically be irritated and inamed, though small relatively asymptomatic stulas may be difcult to nd. The external opening may be obvious or palpated as an indurated region with a concomitant cord. The status of the patients anal sphincter should also be assessed at this time. This examination can be quite uncomfortable for the patient, and it is recommended that it be performed in the operating room under
29 Additional Surgical Options to Treat Anal Fistulas: Gracilis... 475
anesthesia. This will allow for adequate examination of the perianal region and anal canal with probing of the stula.
Advanced imaging can be obtained prior to any exam under anesthesia to assist in identifying any undraine d abscesses or additional stulous tracts. Endorectal ultra­sound (EUS) is useful in assessing sphincter tone in obstetric patients, as well as helps identify stula tracts. Several series have evaluated the utility of EUS with an injection of H202 to determine not only primary tracks but secondary or high­blindtracks as well. A history of colon cancer or other concerning history or symptoms (i.e., bleeding, changes in bowel movements, strong family history) should trigger a complete colonoscopy. Crohn’s disease patients should be offered an MR enterography and colonoscopy with ileoscopy to evaluate the large and small bowel and search for additional lesions. A CT scan is benecial in postsurgical patients to evaluate for anastomotic stulas. MRI and EUS are often the most useful of these imaging modalities as it specically pertains to the stula.
In the operating room, it may still be difcult to identify the stula. It is important to avoid probing the tract aggressively and making false passages that may result in new stulas. In addition, internal openings may be difcult to identify on the rectal side with either direct observation or endoscopy. For rectovaginal stulas, placing a sterile gauze or tamponin the vagina and instilling dilute methylene blue into the rectum can help identify the presence and/or location of the stula by seeing blue on the vaginal gauze. Once the stula is identied, its location, size, quality of the surrounding tissue, sphincter involvement, and prior surgical interventions should be noted and recorded. Any evidence of local sepsis should prompt drainage to allow for adequate tissue healing prior to denitive intervention, including the use of a seton or drain. If the patient has a history of radiation, then the rectum should be evaluated with either rigid or exible proctoscopy (Hrabe and Hull 2020). Biopsies can be performed if there is a concern for malignancy, Crohns disease, or any other concerning ndings on examination. It is critically important at this stage to take full note of the integrity of the surrounding tissue. Remember, options for local aps are dependent on the quality of this tissue to allow for a successful repair. Active inammation, ongoing sepsis, or poor quality will almost guarantee failure even with a technically procient operation.
2.2 Classification
The diverse presentation of anorectal stulas has led to the development of several classication systems in an attempt to standardize categorization, assist in the selection of the treatment, predict the relative complexity of the intervention, and provide an estimate for a successful outcome. Parks et al. developed the most commonly used classication for anorectal stulas in 1976. They described four types of stulas based on their relationship to the external anal sphincter. Type 1 are intersphincteric stulas, which begin at the dentate line and end at the anal verge, tracking between the internal and external anal sphincters. Type 2 are trans-
476 D. Morte et al.
sphincteric stulas that track through the external sphincter into the ischiorectal fossa and exit in the skin overlying the buttock. Type 3 are suprasphincteric stulas, which originate at the anal crypt and circle the entire sphincter complex, terminating in the ischiorectal fossa. Finally, type 4 are extrasphincteric stulas that encompass the entire sphincter muscles to include the levator complex and terminate in the buttock skin. Fistulas are also divided into low or high stulas. Low stulas involve the distal one-third of the external sphincter while high stulas involve greater than half of the external sphincter muscle.
As stated briey, they can also be classied as either simple or complex. Simple stulas are low; have a single external opening, no pain, or uctuance suggesting an abscess; are not a rectovaginal stula; and are not associated with an anorectal stricture, Crohns disease, malignancy, recurrence, or radiation. Complex stulas are high, may have multiple external openings, may have pain and uctuance suggestive of a concomitant abscess, are rectovaginal in nature, may be associated with an anorectal stricture, and/or are a result of underlying Crohns disease, radiation, malignancy, or recurrence.
As rectovaginal stulas are unique and all fall into the criteria of a complex anorectal stula, further attempts to dev elop standardized classi cation schemes have been developed for them. Daniels classied these stulas based on their location with low rectovaginal stulas involving the lower third of the rectum and the lower half of the vagina, and high rectovaginal stulas involve the middle third of the rectum and the upper half of the vagina (Daniels 1949). Rothenberger and associates further classied rectovagina l stulas into simple and complex criteria (1983). Simple rectovaginal stulas are located in the lower or middle third of the vagina, result from trauma or infection, and have a diameter 2.5 cm. Complex rectovaginal stulas originate in the upper third of the vagina; have a diameter 2.5 cm; occur following inammatory bowel disease, radiation, or cancer; or have a history of prior repeated failed repairs. In general, simple stulas can be approached with local repairs and are associated with higher rates of successful healing. On the contrary, complex stulas often require multiple attempts at repair due to higher failure rates, and consideration is often given to the need for diversion and/or secondary aps to bring healthy tissue into the region.
2.3 Treatment Modalities
Due to the varied presentation of anorectal and rectovaginal stulas, there is a wide range of options for their management. The choice of repair depends on the underlying etiology of the stula, its location, symptomatology of the stula, involved structures, and status of the surrounding tissue. Patients that are minimally or asymptomatic may decide to forego any surgical intervention. Fistulas resulting from obstetrical trauma should not be repaired for at least 3 to 6 months, as this will allow some to heal without intervention (Hrabe and Hull 2020). This delay also allows for the inammation of the surrounding structures to resolve and improve the
29 Additional Surgical Options to Treat Anal Fistulas: Gracilis... 477
outcomes of a surgical repair. Patients with stulas secondary to Crohn s disease should be started on biologic therapy, as this has been shown to resolve nearly 50% of stulas (Hrabe and Hull 2020). Any associated abscess should be drained and allowed a period of time prior to intervention to reduce local sepsis. Furthermore, it is important to treat any associated proctitis should local tissue aps (i.e., endorectal aps) be considered.
It is important to adhere to four principles when performing stula surgery: (1) control the underlying sepsis; (2) dene the involved anatomy; (3) treat the underlying process without compromising sphincter function; and (4) minimize the risk of recurrence/maximize the chance of success. Most surgeons will elect to perform a conservative staged approach, with more advanced reconstruction tech­niques reserved for patients that have recurrences. However, it has been suggested that this approach could be a cause for the lower effectiveness of more invasive treatments (Corte et al. 2015). As such, the discussion for the correct choice of procedure should involve an exhaustive discussion with the patient, reviewing their options and the risk and benets associated with each approach.
Biosynthetic materials such as brin glue and collagen plugs are easy-to-use options that induce an inammatory response leading to the closure of the stula. They have the benet of not risking damage to the sphincter mechanism and being easily repeatable. Their efcacy is generally poor, around 10–35%, making these approaches rarely indicated (Gonsalves et al. 2009; Schwandner and Fuerst 2009). Another biosynthetic material that has shown some promise is the use of biosyn­thetic mesh placed between the transected stulous tract. These have been found to have a low success rate of only 20% for complex stulas, but further experience with longer-term follow-up is required to determine their exact place.
Fistulotomy is a commonly used technique with high rates of success for appro­priate patients at a low risk for incontinence with supercial, intersphincteric, or low transsphincteric stulas (Cologne and Langenfeld 2020). This procedure is performed by placing the patient in a prone jackknife position with the buttocks taped apart. Left lateral decubitus and high lithotomy are also acceptable positions, but exposure is generally improved in the prone jackknife position. The external and internal openings of the stula are then identied, and the tract is probed with care taken to avoid the creation of a false tract. Once the stula has been cannulated, the intervening tissue can be divided with the use of electrocautery. The epithelized tract should be curetted or fulgurated and allowed to heal by secondary intention. Success rates for this procedure are high, generally >90%, and fecal incontinence secondary to injury to the anal sphincter should be low when performed in appropriate patients.
A more recent technique developed for the management of transsphincteric stulas is the ligation of the intersphincteric stula tract (LIFT) procedure. This is generally performed as a staged procedure after maturation of the stula tract with the use of a seton . The patient is placed in the prone jackknife position, and the buttocks are taped apart. The stula tract is cannulated. A small 1–2 cm incision is made along the intersphincteric groove, and dissection is continued down to the stula tract. A Lone Star retractor (CooperSurgical) can be used to assist with exposure. The tract is circumferentially dissected, and the probe is removed. Both